Determination of RNA/DNA Damage Associated With Oxidative Stress in Periodontitis Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

88 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-05

Study Completion Date

2025-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study looked at whether a type of gum disease called Stage III periodontitis and cigarette smoking are linked to higher levels of "oxidative stress." Oxidative stress can damage DNA and RNA, which are important parts of our cells. Two markers in saliva-8-OHdG (a sign of DNA damage) and 8-OHG (a sign of RNA damage)-were measured to understand this.

Researchers included four groups of adults: smokers with periodontitis, non-smokers with periodontitis, healthy smokers, and healthy non-smokers. All participants had a dental exam, which checked things like gum inflammation, bleeding, and pocket depth. After the exam, an unstimulated saliva sample was collected from each person. The samples were tested in a laboratory using a sensitive method that measures oxidative damage.

The study found that people with periodontitis had higher levels of DNA and RNA damage in their saliva than healthy people. The highest levels were seen in smokers with periodontitis. Even healthy smokers showed higher levels of oxidative stress than healthy non-smokers. In general, worse gum disease was linked to higher levels of oxidative damage.

These results suggest that saliva tests for 8-OHdG and 8-OHG may help identify gum disease in a simple, non-invasive way. The findings also show that smoking adds to the body's oxidative stress, especially when gum disease is present. The study provides new information about how smoking and gum disease together may affect cell health.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effects of Smoking on miRNA-223 Before-After Non-Surgical Periodontal Therapy

NCT05372965

Periodontal Therapy miRNA-223 Periodontitis +1 more

COMPLETED NA

Effects of Smoking on Oral Tissue Samples

NCT05484765

Histopathology Periodontitis Smoking +1 more

COMPLETED

Potential Effect for the Smoking on Periodontitis From the Perspective of Arginine Metabolites

NCT05448976

Periodontitis Smoking Inflammatory Response

COMPLETED NA

EVALUATION OF SALIVA AND SERUM HEME OXYGENASE, ARYLESTERASE AND NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2 LEVELS IN PATIENTS WITH STAGE III PERIODONTITIS

NCT06986044

Periodontal Health Periodontitis Stage III

COMPLETED

Nitro-oxidative Stress in Periodontitis

NCT02127203

Chronic Periodontitis Aggressive Periodontitis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Periodontitis is a chronic inflammatory disease that leads to the progressive destruction of the tooth-supporting tissues. Oxidative stress plays a central role in its pathogenesis, as excessive production of reactive oxygen species (ROS) can damage cellular structures, including lipids, proteins, and nucleic acids. Among oxidative stress-related biomarkers, 8-hydroxy-2'-deoxyguanosine (8-OHdG) and 8-hydroxyguanosine (8-OHG) are widely recognized indicators of DNA and RNA damage, respectively. These biomarkers reflect the biochemical consequences of oxidative stress and are increasingly used to evaluate host responses in periodontal disease.

Cigarette smoking is one of the strongest environmental risk factors for periodontitis and is known to enhance oxidative stress through multiple mechanisms. However, the combined effect of smoking and advanced periodontitis on salivary oxidative DNA and RNA damage has not been fully clarified. Assessing both 8-OHdG and 8-OHG simultaneously may provide deeper insight into the molecular pathways linking smoking, inflammation, and periodontal tissue destruction.

This study was designed to evaluate salivary levels of oxidative nucleic acid damage in individuals with Stage III periodontitis who smoke or do not smoke, as well as in periodontally healthy controls. The study also aimed to investigate the relationship between these biomarkers and clinical periodontal measurements. By examining DNA and RNA oxidation together, the study sought to provide a multidimensional understanding of the host oxidative response in periodontitis.

All participants underwent full-mouth periodontal examination performed by a calibrated clinician. Unstimulated saliva samples were collected under standardized morning conditions, processed by centrifugation to remove cellular debris, and stored at -80°C until biochemical analysis. Levels of 8-OHdG and 8-OHG were quantified using a high-sensitivity ELISA method capable of detecting multiple oxidized guanine derivatives.

Biochemical findings demonstrated that oxidative DNA and RNA damage levels were higher in individuals with periodontitis compared to healthy controls, with smokers exhibiting the highest levels overall. Oxidative biomarker levels showed positive correlations with key periodontal parameters, including probing depth, clinical attachment loss, plaque accumulation, gingival inflammation, and bleeding on probing. These results suggest that the inflammatory burden of periodontitis amplifies oxidative stress at the nucleic acid level and that smoking contributes an additional biological load.

In addition to biochemical assessment, buccal mucosa samples were evaluated cytologically using hematoxylin and eosin staining. All specimens showed adequate cellularity, and no significant differences in epithelial dysplasia were observed across study groups. This may be related to the predominance of superficial epithelial cells in the collected samples.

Overall, this study provides an integrated biochemical and cytomorphological assessment of oxidative stress in periodontitis. The findings support the potential use of salivary 8-OHdG and 8-OHG as non-invasive biomarkers for disease monitoring and contribute novel evidence regarding the interaction between smoking, oxidative stress, and periodontal inflammation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Periodontitis (Stage 3) Smoking

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Periodontitis Smoker

Participants diagnosed with Stage III periodontitis who are current cigarette smokers. No intervention was applied; biological samples (unstimulated saliva) were collected for biomarker analysis.

No interventions assigned to this group

Periodontitis Non-Smoker

Participants diagnosed with Stage III periodontitis who do not smoke. No intervention was applied; unstimulated saliva samples were collected for laboratory analysis.

No interventions assigned to this group

Healthy Smoker

Periodontally healthy individuals who are current smokers. No treatment or intervention was performed; only saliva samples and periodontal measurements were obtained.

No interventions assigned to this group

Healthy Non-Smoker

Periodontally healthy non-smokers. No intervention was provided; participants underwent periodontal evaluation and saliva sample collection.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals aged 18 years or older
* Having at least 16 permanent teeth, excluding third molars
* Not using orthodontic appliances
* Not pregnant or breastfeeding
* Systemically healthy individuals with no systemic diseases that could affect periodontal status
* No use of anti-inflammatory or antimicrobial medications within the last 6 months
* No periodontal treatment within the last 12 months

Exclusion Criteria

* Pregnant or breastfeeding individuals.
* Use of anti-inflammatory or antimicrobial drugs in the past 6 months.
* Use of antioxidant supplements in the past 3 months.
* Periodontal treatment within the past 12 months.
* Diagnosis of psychiatric disorders.
* Any oral infection.
* Fewer than 16 permanent teeth (excluding third molars).
* Alcohol dependence.
* Active infectious diseases (Acute hepatitis, AIDS, tuberculosis), malignancy, or any systemic condition that may affect periodontal tissues.
* Current use of medications known to affect periodontal tissues (phenytoin, cyclosporine A, calcium channel blockers).

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes